These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 10655528)

  • 1. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.
    Imagawa A; Hanafusa T; Miyagawa J; Matsuzawa Y
    N Engl J Med; 2000 Feb; 342(5):301-7. PubMed ID: 10655528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus.
    Imagawa A; Hanafusa T; Itoh N; Waguri M; Yamamoto K; Miyagawa J; Moriwaki M; Yamagata K; Iwahashi H; Sada M; Tsuji T; Tamura S; Kawata S; Kuwajima M; Nakajima H; Namba M; Matsuzawa Y
    Diabetologia; 1999 May; 42(5):574-8. PubMed ID: 10333050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-autoimmune fulminant type 1 diabetes].
    Sanke T
    Rinsho Byori; 2001 Dec; 49(12):1185-9. PubMed ID: 11797386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
    Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
    Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients: association of hyperlipasemia with high-titer islet cell antibodies. Belgian Diabetes Registry.
    Semakula C; Vandewalle CL; Van Schravendijk CF; Sodoyez JC; Schuit FC; Foriers A; Falorni A; Craen M; Decraene P; Pipeleers DG; Gorus FK
    Pancreas; 1996 May; 12(4):321-33. PubMed ID: 8740397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
    Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating anti-glutamic acid decarboxylase-65 antibody titers are positively associated with the capacity of insulin secretion in acute-onset type 1 diabetes with short duration in a Japanese population.
    Yamamura S; Fukui T; Mori Y; Hayashi T; Yamamoto T; Ohara M; Fukase A; Sasamori H; Kobayashi T; Hirano T
    J Diabetes Investig; 2019 Nov; 10(6):1480-1489. PubMed ID: 30919585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians.
    Singh AK; Bhatia E; Dabadghao P; Bhatia V; Gellert SA; Colman PG
    Diabet Med; 2000 Apr; 17(4):275-80. PubMed ID: 10821293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.
    Tuomi T; Groop LC; Zimmet PZ; Rowley MJ; Knowles W; Mackay IR
    Diabetes; 1993 Feb; 42(2):359-62. PubMed ID: 8425674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study.
    Davis TM; Zimmet P; Davis WA; Bruce DG; Fida S; Mackay IR
    Diabet Med; 2000 Sep; 17(9):667-74. PubMed ID: 11051287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?
    Tiberti C; Buzzetti R; Anastasi E; Dotta F; Vasta M; Petrone A; Cervoni M; Torresi P; Vecci E; Multari G; Di Mario U
    Diabetes Metab Res Rev; 2000; 16(1):8-14. PubMed ID: 10707033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
    Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
    Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy.
    Bosi EP; Garancini MP; Poggiali F; Bonifacio E; Gallus G
    Diabetologia; 1999 Jul; 42(7):840-4. PubMed ID: 10440126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Stene LC; Barriga K; Hoffman M; Kean J; Klingensmith G; Norris JM; Erlich HA; Eisenbarth GS; Rewers M
    Pediatr Diabetes; 2006 Oct; 7(5):247-53. PubMed ID: 17054445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.